U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950488) titled 'Clinical Characteristics and Long-Term Outcomes of Patients With Valvular Heart Disease' on... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951151) titled 'California Community Engagement Alliance: A California Consortium to Enhance Social Needs C... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950540) titled 'Proactive Therapy of Acute Radiation-induced Skin Injury in Head and Neck Cancer' on Nov. 0... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951775) titled 'Comparison Evaluation of the Accuracy of Two Digital Technologies of Measuring Sagittal Con... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951021) titled 'Chemotherapy-Minimized Blank Microsphere Transarterial Embolization (BMS-TACE) Plus Low-Dos... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951463) titled 'A Study of Glumetinib in Combination With Osimertinib as 1st Line Treatment in Patients Wit... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950735) titled 'Online Mindfulness-based Visualisation to Treat Visual Overload in Persistent Postural Perc... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951515) titled 'A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Macular Edema Afte... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07949981) titled 'Celiac Versus Splanchnic Neurolysis in Abdominal Malignancies' on Sept. 17. Brief Summary:... Read More
U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950267) titled 'Real-world Evidence of Inebilizumab in IgG4-RD' on Nov. 08. Brief Summary: The goal of thi... Read More